Rate My Professor Mary Wallace

Her research involves genetic analyses, particularly genotyping for studies on rheumatic diseases, gout, and population genetics. Key publications include 'Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity' (2013, co-authored with R.L. Roberts et al.), which examined the distribution of the HLA-B27 allele linked to spondyloarthropathies across ethnic groups and age ranges in New Zealand. She contributed to 'Association between ABCG2 rs2231142 and Poor Response to Allopurinol: Replication and Meta-Analysis' (2017), analyzing genetic predictors of treatment response in gout patients. Other notable works are 'The oral microbiome of patients with axial spondyloarthritis is distinct from healthy controls' (2016, PeerJ), investigating microbial profiles in disease; 'ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in patients with gout' (2018, published in Arthritis Research & Therapy); 'Plasma oxypurinol as a measure of adherence in clinical trials of allopurinol for gout' (2024); and 'Characterization of a gene encoding an acetylase required for virulence in Pseudomonas aeruginosa' (2006, Journal of Bacteriology). Wallace performed genotyping for renal function studies related to gentamicin and other research projects at Otago, including PhD theses on renal function (2014). Her collaborations span the Department of Medicine, Dunedin School of Medicine, Department of Surgical Sciences, and Zoology, supporting advancements in medical genetics and microbiology.